Saeed Dabestani

Sökresultat

• 2025

  Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma

  Bedke, J., Ghanem, Y. A., Albiges, L., Bonn, S., Campi, R., Capitanio, U., Dabestani, S., Hora, M., Klatte, T., Kuusk, T., Lund, L., Marconi, L., Palumbo, C., Pignot, G., Powles, T., Tran, M., Volpe, A. & Bex, A., 2025 apr., I: European Urology. 87, 4, s. 491-496 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Clear Cell Renal Cell Carcinoma 100%
  • Urology 100%
  • Immune Checkpoint Inhibitor 100%
  • Pembrolizumab 87%
  • Recurrent Disease 50%
• 2023

  suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma

  Azawi, N., Mosholt, K. S. S., Fryd, N. D., Lund, L., Brignone, J. I., Hvid, N., Wulf-Johansson, H., Pedersen, O. B. V., Saekmose, S. G. & Dabestani, S., 2023 dec., I: BMC Urology. 23, 1, 168.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Overall Survival 33%
  • Follow up 22%
  • Therapeutic Procedure 11%

• Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups

  Marconi, L., Kuusk, T., Capitanio, U., Beisland, C., Lam, T., Pello, S. F., Stewart, G. D., Klatte, T., Volpe, A., Ljungberg, B., Dabestani, S. & Bex, A., 2023 jan., I: European Urology Open Science. 47, s. 65-72 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Clear Cell Renal Cell Carcinoma 100%
  • Local Therapy 100%
  • Risk 100%
  • Survival 100%
  • Renal Cell Carcinoma 100%

• The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

  Bedke, J., Albiges, L., Capitanio, U., Giles, R. H., Hora, M., Ljungberg, B., Marconi, L., Klatte, T., Volpe, A., Abu-Ghanem, Y., Dabestani, S., Fernández-Pello, S., Hofmann, F., Kuusk, T., Tahbaz, R., Powles, T. & Bex, A., 2023 jan., I: European Urology. 83, 1, s. 10-14 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Therapeutic Procedure 100%
  • Association 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Urology 100%
  • Immune Checkpoint Inhibitor 100%

• Incidence and associated risk factors of venous thromboembolism after open and laparoscopic partial nephrectomy in patients administered short-period thromboprophylaxis: a Danish nationwide population-based cohort study

  Azawi, N. H., Tolouee, S. & Dabestani, S., 2023, I: Scandinavian Journal of Urology. 57, 1-6, s. 81-85 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Cohort Analysis 100%
  • Thromboprophylaxis 100%
  • Partial Nephrectomy 100%
  • Hospital 22%
• 2022

  Noninvasive detection of any-stage cancer using free glycosaminoglycans

  Bratulic, S., Limeta, A., Dabestani, S., Birgisson, H., Enblad, G., Stålberg, K., Hesselager, G., Häggman, M., Höglund, M., Simonson, O. E., Stålberg, P., Lindman, H., Bång-Rudenstam, A., Ekstrand, M., Kumar, G., Cavarretta, I., Alfano, M., Pellegrino, F., Mandel-Clausen, T. & Salanti, A. & 16 andra, Maccari, F., Galeotti, F., Volpi, N., Daugaard, M., Belting, M., Lundstam, S., Stierner, U., Nyman, J., Bergman, B., Edqvist, P. H., Levin, M., Salonia, A., Kjölhede, H., Jonasch, E., Nielsen, J. & Gatto, F., 2022 dec., I: Proceedings of the National Academy of Sciences of the United States of America. 119, 50, e2115328119.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cancer Staging 100%
  • Glycosaminoglycan 100%
  • Blood Plasma 100%
  • Biological Marker 80%
  • Screening 50%

• Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)

  Fallara, G., Larcher, A., Dabestani, S., Fossati, N., Järvinen, P., Nisen, H., Gudmundsson, E., Lam, T. B., Marconi, L., Fernandéz-Pello, S., Meijer, R. P., Volpe, A., Beisland, C., Klatte, T., Stewart, G. D., Bensalah, K., Ljungberg, B., Bertini, R., Montorsi, F. & Bex, A. & 1 andra, Capitanio, U., 2022 nov., I: Urologic Oncology: Seminars and Original Investigations. 40, 11, s. 494.e11-494.e17

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Clear Cell Renal Cell Carcinoma 100%
  • Renal Cell Carcinoma 100%
  • Metastasis 100%
  • Minimally Invasive Surgery 62%
  • Patient 37%

• Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study

  Gatto, F., Dabestani, S., Bratulic, S., Limeta, A., Maccari, F., Galeotti, F., Volpi, N., Stierner, U., Nielsen, J. & Lundstam, S., 2022 aug., I: European Urology Open Science. 42, s. 30-39 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cells 100%
  • Biological Marker 100%
  • Urine 100%
  • Prospective Cohort Study 100%
  • Glycosaminoglycan 100%

• 2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

  Bedke, J., Albiges, L., Capitanio, U., Giles, R. H., Hora, M., Lam, T. B., Ljungberg, B., Marconi, L., Klatte, T., Volpe, A., Abu-Ghanem, Y., Dabestani, S., Fernández-Pello, S., Hofmann, F., Kuusk, T., Tahbaz, R., Powles, T. & Bex, A., 2022 feb., I: European Urology. 81, 2, s. 134-137 4 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Association 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Urology 100%
  • Metastasectomy 66%
  • Patient 50%
• 2021

  The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium

  Abu-Ghanem, Y., Powles, T., Capitanio, U., Beisland, C., Järvinen, P., Stewart, G. D., Gudmundsson, E. O., Lam, T. B., Marconi, L., Fernandéz-Pello, S., Nisen, H., Meijer, R. P., Volpe, A., Ljungberg, B., Klatte, T., Dabestani, S. & Bex, A., 2021 juni 1, I: European Urology Oncology. 4, 3, s. 473-482 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Surgery 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Follow up 36%
  • Clear Cell 27%

• Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma

  Bedke, J., Albiges, L., Capitanio, U., Giles, R. H., Hora, M., Lam, T. B., Ljungberg, B., Marconi, L., Klatte, T., Volpe, A., Abu-Ghanem, Y., Dabestani, S., Fernández-Pello, S., Hofmann, F., Kuusk, T., Tahbaz, R., Powles, T. & Bex, A., 2021 mars, I: European Urology. 79, 3, s. 339-342 4 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Therapeutic Procedure 100%
  • Association 100%
  • Combination Therapy 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Cabozantinib 100%

• A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound

  Rossi, S. H., Klatte, T., Usher-Smith, J. A., Fife, K., Welsh, S. J., Dabestani, S., Bex, A., Nicol, D., Nathan, P., Stewart, G. D. & Wilson, E. C. F., 2021, I: European Urology Focus. 7, 2, s. 407-419

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Man 100%
  • Age 100%
  • Health Care Cost 100%

• Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma

  Neves, J. B., Vanaclocha Saiz, L., Abu-Ghanem, Y., Marchetti, M., Tran-Dang, M. A., El-Sheikh, S., Barod, R., Beisland, C., Capitanio, U., Cullen, D., Klatte, T., Ljungberg, B., Mumtaz, F., Patki, P., Stewart, G. D., Dabestani, S., Tran, M. G. B., Bex, A. & the RECUR consortium, 2021, I: World Journal of Urology. 39, 10, s. 3823-3831

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Surgery 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Death 62%
  • Patient 37%
  • Follow up 37%

• Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials

  Marconi, L., Sun, M., Beisland, C., Klatte, T., Ljungberg, B., Stewart, G. D., Dabestani, S., Choueiri, T. K. & Bex, A., 2021, I: Clinical Genitourinary Cancer. 19, 2, s. e92-e99

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Prevalence 100%
  • Renal Cell Carcinoma 100%
  • Malignant Neoplasm 75%
  • Recurrent Disease 25%
  • Neoplasm 25%

• Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?

  Abu-Ghanem, Y., Powles, T., Capitanio, U., Beisland, C., Järvinen, P., Stewart, G. D., Gudmundsson, E., Lam, T. B. L., Marconi, L., Fernandéz-Pello, S., Nisen, H., Meijer, R. P., Volpe, A., Ljungberg, B., Klatte, T., Bensalah, K., Dabestani, S. & Bex, A., 2021, I: BJU International. 128, 3, s. 386-394

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Radical Nephrectomy 100%
  • Recurrent Disease 100%
  • Renal Cell Carcinoma 100%
• 2020

  Incidence and Associated Risk Factors of Venous Thromboembolism After Open and Laparoscopic Nephrectomy in Patients Administered Short-period Thromboprophylaxis: A Danish Nationwide Population-based Cohort Study

  Azawi, N. H., Subhi, Y., Tolouee, S., Geertsen, L., Bjerrum, S. N., Laier, G. H., Dahl, C., Lund, L. & Dabestani, S., 2020 sep. 1, I: Urology. 143, s. 112-116 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Cohort Analysis 100%
  • Thromboprophylaxis 100%
  • Nephrectomy 100%
  • Odds Ratio 55%

• Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel

  Abu-Ghanem, Y., Fernández-Pello, S., Bex, A., Ljungberg, B., Albiges, L., Dabestani, S., Giles, R. H., Hofmann, F., Hora, M., Kuczyk, M. A., Kuusk, T., Marconi, L., Merseburger, A. S., Tahbaz, R., Staehler, M., Volpe, A., Powles, T., Lam, T. B. & Bensalah, K., 2020, I: European Urology Oncology. 3, 4, s. 433-452 20 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Association 100%
  • Cancer Cell 100%
  • Catheter Ablation 100%
  • Systematic Review 100%
• 2019

  Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis

  Dabestani, S., Beisland, C., Stewart, G. D., Bensalah, K., Gudmundsson, E., Lam, T. B., Gietzmann, W., Zakikhani, P., Marconi, L., Fernandéz-Pello, S., Monagas, S., Williams, S. P., Torbrand, C., Powles, T., Van Werkhoven, E., Meijer, R., Volpe, A., Staehler, M., Ljungberg, B. & Bex, A., 2019 sep., I: European Urology Focus. 5, 5, s. 857-866 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Follow up 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Renal Cell Carcinoma 100%
  • Survival 66%

• European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

  Ljungberg, B., Albiges, L., Abu-Ghanem, Y., Bensalah, K., Dabestani, S., Montes, S. F. P., Giles, R. H., Hofmann, F., Hora, M., Kuczyk, M. A., Kuusk, T., Lam, T. B., Marconi, L., Merseburger, A. S., Powles, T., Staehler, M., Tahbaz, R., Volpe, A. & Bex, A., 2019 maj, I: European Urology. 75, 5, s. 799-810 12 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Association 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Urology 100%
  • Practice Guideline 100%
  • Randomized Controlled Trial 50%

• Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C. results from a European multicenter database (R.E.C.U.R.)

  Dabestani, S., Beisland, C., Stewart, G. D., Bensalah, K., Gudmundsson, E., Lam, T. B., Gietzmann, W., Zakikhani, P., Marconi, L., Fernandéz-Pello, S., Monagas, S., Williams, S. P., Powles, T., Van Werkhoven, E., Meijer, R., Volpe, A., Staehler, M., Ljungberg, B. & Bex, A., 2019, I: Scandinavian Journal of Urology. 53, 1, s. 14-20

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

  Albiges, L., Powles, T., Staehler, M., Bensalah, K., Giles, R. H., Hora, M., Kuczyk, M. A., Lam, T. B., Ljungberg, B., Marconi, L., Merseburger, A. S., Volpe, A., Abu-Ghanem, Y., Dabestani, S., Fernández-Pello, S., Hofmann, F., Kuusk, T., Tahbaz, R. & Bex, A., 2019, I: European Urology. 76, 2, s. 151-156

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Therapeutic Procedure 100%
  • Association 100%
  • Spine 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Urology 100%
• 2018

  Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer

  Powles, T., Albiges, L., Staehler, M., Bensalah, K., Dabestani, S., Giles, R. H., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T. B., Marconi, L., Merseburger, A. S., Fernández-Pello, S., Tahbaz, R., Volpe, A., Ljungberg, B. & Bex, A., 2018 mars 1, I: European Urology. 73, 3, s. 311-315 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Therapeutic Procedure 100%
  • Association 100%
  • Urology 100%
  • Clear Cell 100%
• 2017

  Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma

  Bex, A., Albiges, L., Ljungberg, B., Bensalah, K., Dabestani, S., Giles, R. H., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T. B., Marconi, L., Merseburger, A. S., Staehler, M., Volpe, A. & Powles, T., 2017, I: European Urology. 71, 5, s. 719-722

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Association 100%
  • Adjuvant Therapy 100%
  • Clear Cell Renal Cell Carcinoma 100%
  • Urology 100%
• 2016

  Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.

  Dabestani, S., Thorstenson, A., Lindblad, P., Harmenberg, U., Ljungberg, B. & Lundstam, S., 2016, I: World Journal of Urology.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Metastasectomy 100%
  • Partial Nephrectomy 50%
  • Radical Nephrectomy 50%
  • Minimally Invasive Procedure 50%
• 2015

  EAU Guidelines on Renal Cell Carcinoma: 2014 Update.

  Ljungberg, B., Bensalah, K., Canfield, S., Dabestani, S., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T., Marconi, L., Merseburger, A. S., Mulders, P., Powles, T., Staehler, M., Volpe, A. & Bex, A., 2015, I: European Urology. 67, 5, s. 913-924

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Clear Cell Renal Cell Carcinoma 100%
  • Association 33%
  • Urology 33%